MedTrace Logo

Usefulness of the VExUS Protocol for Dry-Weight Adjustment in Hemodialysis Patients: The Multicenter VExHD Study

NCT07659197 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-06-24

No results posted yet for this study

Summary

The objective of this prospective observational study is to determine the utility of ultrasonographic assessment using the VExUS protocol for dry weight adjustment in clinically euvolemic patients undergoing hemodialysis.

The primary hypothesis is that the assessment of venous congestion by ultrasound may help identify patients who can tolerate increased ultrafiltration, thereby improving blood pressure control.

The comparison group will consist of patients who do not meet the criteria for venous congestion according to the VExUS protocol.

In patients meeting the criteria for venous congestion, the ultrafiltration volume during hemodialysis will be increased.

Conditions

  • Hypertension (HTN)
  • Hemodialysis

Interventions

BEHAVIORAL

Increased ultrafiltration

In patients meeting the predefined ultrasonographic criteria for venous congestion, the prescribed dry weight will be reduced by 0.3 kg per week, resulting in a corresponding increase in the ultrafiltration volume during hemodialysis sessions.

BEHAVIORAL

No increase in ultrafiltration

In patients who do not meet the predefined ultrasonographic criteria for venous congestion, the ultrafiltration prescription will remain unchanged.

Sponsors & Collaborators

  • SOMANE (MADRID SOCIETY OF NEPHROLOGY)

    collaborator UNKNOWN

  • Fundación Senefro

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-06-01
Completion
2025-09-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07659197 on ClinicalTrials.gov